BackAlkermes plc Overview
Alkermes plc

Alkermes plc Target Price

Analysts' average 12-month price target for Alkermes plc is $59.

Get informed when a big investor buys or sells

+ Follow

Share Price

$49.67

Average Target Price

$58.8318.4% upside

6 analysts in the last 4 months

High: $65 | Low: $50

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-28Piper SandlerDavid Amsellem$6530.9% upsideOpen
2026-07-20Stifel NicolausPaul Matteis$6326.8% upsideOpen
2026-07-02Mizuho SecuritiesVamil Divan$6530.9% upsideOpen
2026-06-18NeedhamAmi Fadia$548.7% upsideOpen
2026-06-09RBC CapitalLeonid Timashev$5612.7% upsideOpen
2026-05-06Needham$500.7% upsideOpen
2026-02-26H.C. WainwrightDouglas Tsao$4313.4% downsideOpen
2026-02-23Wolfe Research$459.4% downsideOpen
2025-10-28JefferiesAkash Tewari$5612.7% upsideOpen
2025-10-27Mizuho Securities$459.4% downsideOpen
2025-10-23Piper SandlerDavid Amsellem$459.4% downsideOpen
2025-10-22RBC Capital$475.4% downsideOpen
2025-09-26RBC CapitalAlkermes to Outperform$4411.4% downsideOpen
2025-09-09Needham$4313.4% downsideOpen
2025-09-09H.C. WainwrightDouglas Tsao$467.4% downsideOpen
2025-09-02Wells Fargo$4411.4% downsideOpen
2025-06-17UBSAshwani Verma$4215.4% downsideOpen
2024-12-05Piper SandlerDavid Amsellem$3725.5% downsideOpen
2024-11-13Mizuho SecuritiesVamil Divan$4019.5% downsideOpen
2024-11-04Stifel NicolausPaul Matteis$3627.5% downsideOpen
2024-10-24Stifel NicolausPaul Matteis$2549.7% downsideOpen
2024-10-14H.C. WainwrightDouglas Tsao$3725.5% downsideOpen
2024-04-10JefferiesAkash Tewari$2549.7% downsideOpen
2024-04-09Mizuho SecuritiesVamil Divan$3529.5% downsideOpen
2024-04-09JefferiesAkash Tewari$2549.7% downsideOpen
2024-03-18Robert W. BairdJoel Beatty$3725.5% downsideOpen
2022-12-06J.P. Morgan$2941.6% downsideOpen
2022-04-28Leerink Partners$2745.6% downsideOpen
2022-04-21Leerink Partners$2549.7% downsideOpen
2022-04-20Goldman Sachs$3529.5% downsideOpen

Alkermes plc (ALKS) FAQ

As of the most recent data, ALKS shows a target price of $59. Scroll down for historical charts and peer comparison views.

If Alkermes plc moved to the average analyst target of $59, shares would be roughly 18.4% higher than $49.67. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Alkermes plc's earnings trajectory.

Besides this target price page, Stockcircle has Alkermes plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $59) with ownership activity and broader fundamentals.

Alkermes plc's target price is $59; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.